Clinical trial
Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced…
NCT00079079 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00079079 |
|---|---|
| Title | Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor |
| Official title | A Phase II Study of Cisplatin and Gemcitabine in Patients With Locally Advanced/Recurrent or Metastatic Malignant Salivary Gland Tumors |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, cisplatin, gemcitabine hydrochloride |
| Enrollment | 34 |
| Start date | Oct 27, 2003 |
| Primary completion | Sep 29, 2008 |
| Completion | Feb 10, 2009 |
| First posted | Mar 9, 2004 |
| Last update posted | Aug 4, 2023 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: